2179 fundamentals
Key facts
About
Jiangsu Recbio Technology Co., Ltd. engages in the research and development of vaccines. It focuses on innovative technology platforms such as novel adjuvant, protein engineering, and immunological evaluation platforms. The company was founded by Yong Liu on May 18, 2012 and is headquartered in Taizhou City, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
2179 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company